Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

People who have a transient ischemic attack (TIA) should get aggressive treatment to help protect cognitive health, a new study suggests.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

RapidAI automated imaging appeared to be more accurate than VizAI in detecting cases of large vessel occlusion, as well as in ...